Spend related to diabetes presents a huge financial burden for the 37 million Americans living with diabetes and the 100 million prediabetic adults in the form of inpatient stays, medications, provider office visits and antidiabetic medications and supplies, such as testing strips.
Uncontrolled diabetes presents the most significant cost challenge for payers as those
without good self-care habits are more likely to be hospitalized at a significant expense.